Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 2,889 | 2,081 | 4,670 | 1,769 | 679 |
| Cost of Goods | 2,088 | 1,952 | 4,248 | 1,675 | 523 |
| Gross Profit | 801 | 129 | 422 | 94 | 156 |
| Operating Expenses | 7,254 | 9,801 | 7,318 | 10,700 | 8,543 |
| Operating Income | -6,365 | -8,720 | -6,648 | -9,931 | -7,864 |
| Other Income | -52,783 | 6,096 | -642 | -805 | -662 |
| Pre-tax Income | -59,148 | -2,624 | -7,290 | -10,736 | -8,526 |
| Net Income Continuous | -59,148 | -2,624 | -7,290 | -10,736 | -8,526 |
| Net Income Discontinuous | N/A | N/A | N/A | -117 | -72 |
| Net Income | $-59,148 | $-2,624 | $-7,290 | $-10,853 | $-8,598 |
| EPS Basic Total Ops | -4.80 | -0.20 | -0.70 | -1.10 | -0.90 |
| EPS Basic Continuous Ops | -4.75 | -0.17 | -0.73 | -1.10 | -0.90 |
| EPS Basic Discontinuous Ops | N/A | -0.01 | N/A | -0.01 | 0.00 |
| EPS Diluted Total Ops | -4.80 | -0.20 | -0.70 | -1.10 | -0.90 |
| EPS Diluted Continuous Ops | -4.75 | -0.20 | -0.70 | -1.10 | -0.90 |
| EPS Diluted Discontinuous Ops | N/A | -0.01 | N/A | -0.01 | 0.00 |
| EBITDA(a) | $-5,283 | $-7,991 | $-6,053 | $-9,330 | $-7,238 |